Peptide Pool Screening

Peptide pool screening is an immunological method that uses mixtures of synthetic peptides to test whether immune cells recognize specific protein antigens. Overlapping peptides are incubated with peripheral blood mononuclear cells or other responder cells, and antigen-specific T-cell activation is measured through cytokine release, intracellular staining, or ELISpot assays. In infection research, this approach evaluates cellular responses to viruses, bacteria, and other pathogens without requiring the complete pathogen, helping identify immunogenic regions and characterize immune memory. It supports vaccine development, infectious disease studies, immune monitoring, and the assessment of patient-specific responses to defined antigens.

Peptide Pool Screening - Related Videos

Research

JoVE Journal - Chemistry

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

0 Views •

Cited by 5 •

2014

Peptide tertiary amides (PTAs) are a superfamily of peptidomimetics that include but are not limited to peptides, peptoids and N-methylated peptides. Here we describe a synthetic method which combines both split-and-pool and sub-monomer strategies to synthesize a one-bead one-compound library of PTAs.

Research

JoVE Journal - Biology
Free Sample

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells

0 Views •

Cited by 11 •

2011

Here we use a human LentiPlex pooled library and traditional sequencing methods to identify gene targets promoting cell survival. We demonstrate how to set up and deconvolute a LentiPlex screen and validate the results.

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

0 Views •

Cited by 2 •

2018

We report a small hairpin RNA (shRNA) and next generation sequencing-based protocol for identifying regulators of X-chromosome inactivation in a murine cell line with firefly luciferase and hygromycin resistance genes fused to the methyl CpG binding protein 2 (MeCP2) gene on the inactive X chromosome.

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

0 Views •

Cited by 14 •

2019

CRISPR-Cas9 technology provides an efficient method to precisely edit the mammalian genome in any cell type and represents a novel means to perform genome-wide genetic screens. A detailed protocol discussing the steps required for the successful performance of pooled genome-wide CRISPR-Cas9 screens is provided here.

A Fluorogenic Peptide Cleavage Assay to Screen the Proteolytic Activity of Proteases

0 Views •

2025

This video demonstrates an assay to screen for the proteolytic activity of proteases using fluorogenic peptides. The protease recognizes its cleavage site on the peptide, cleaving it and separating the quencher from the fluorophore, enabling its fluorescence emission. The fluorescence signal is detected and analyzed to check for the cleavage efficiency of different peptide variants.

View All Results

FAQs

Related Topics